関連する実験動画
Updated: Sep 8, 2025
07:55
The Influence of Liver Resection on Intrahepatic Tumor Growth
Published on: April 9, 2016
9.5K
ボスロップス毒の生化学に対する肝臓新生体の影響の調査
Caroline Tie Vespasiano1, Caroline Serino-Silva2, Giovanni Perez Machado Silveira2
1Laboratory of Herpetology, Butantan Institute, São Paulo, SP, Brazil; Interinstitutional Graduate Program in Biotechnology (PPIB-IPT, IBU and USP), University of São Paulo (USP), São Paulo, SP, Brazil.
Toxicon : official journal of the International Society on Toxinology
|September 5, 2025
まとめ
ボトロップスヘビの肝臓腫瘍は毒の組成や酵素活性を変えず,抗毒生成に適している. この発見は 肝臓に問題がある捕獲ヘビを 抗毒剤の製造に使うことを支持しています
科学分野:
- ヘルペトロジーと毒理学
- 生物化学と分子生物学
- 公衆衛生と熱帯医学
背景:
- 蛇の毒は 特に熱帯地域では 世界的な健康問題です
- ボスロップスの毒は ブラジルの抗毒剤の生産に不可欠です
- ヘビの毒の成分に対する肝臓腫瘍の影響はほとんど不明である.
研究 の 目的:
- 肝臓の腫瘍やキスタがボスロップス毒の生化学プロファイルと酵素活性に影響するかどうかを調べる.
- 抗毒剤の生成のための毒の質に対する肝臓の変化の影響を評価する.
主な方法:
- SDS-PAGE,ウエスタン・ブロッティング,ELISA,RP-HPLCを用いた17匹のボスロップスヘビ (8匹は肝臓の変異,9匹は健康) の毒の分析.
- タンパク質分解活性,L-アミノ酸酸化酵素,最小凝固剤用量を含む酵素活性アッセイが実施された.
- 商用抗ボトロピク抗毒剤による毒の免疫活性が評価された.
主要な成果:
- 肝臓の状態とは無関係に高濃度内および異種間の毒の変動が観察されました.
- 肝臓の腫瘍は毒のタンパク質の構成や酵素活動に 顕著な変化を伴う傾向はない.
- 商用抗ボトロピク抗毒剤は,すべての毒素サンプルに対して有効でした.
結論:
- 肝臓の腫瘍やキスタは ボスロップスの毒の生化学的整合性を損ねません
- 抗毒剤の生成に適した毒は これらの肝臓病変によって影響を受けません
- 肝臓に損傷がある蛇は公衆衛生上の目的で 毒を抽出するのに有効です
関連する概念動画
01:16Hepatic Drug Excretion: Influencing Factors
214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214
01:09Hepatic Drug Clearance: Effect of Protein Binding
284
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
284
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:26Toxic Reactions: Overview
1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
01:21Hepatic Portal System
2.0K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
2.0K
01:19Factors Affecting Drug Biotransformation: Biological
230
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
230